| P50 | author | Solbritt Rantapää-Dahlqvist | Q30501391 |
| | Lotta Ljung | Q55979204 |
| | Lennart T. H. Jacobsson | Q110625350 |
| P2093 | author name string | Johan Askling | |
| | ARTIS Study Group | |
| P2860 | cites work | EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis | Q33505914 |
| | Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis | Q34182804 |
| | Etanercept, infliximab, and leflunomide in established rheumatoid arthritis: clinical experience using a structured follow up programme in southern Sweden. | Q35551908 |
| | Increased incidence of cardiovascular disease in patients with rheumatoid arthritis: results from a community based study | Q35554431 |
| | Cardiovascular events in early RA are a result of inflammatory burden and traditional risk factors: a five year prospective study | Q35617716 |
| | Swedish registers to examine drug safety and clinical issues in RA. | Q35637262 |
| | Increased incidence of and impaired prognosis after acute myocardial infarction among patients with seropositive rheumatoid arthritis | Q35638708 |
| | All-cause and cause-specific mortality in rheumatoid arthritis are not greater than expected when treated with tumour necrosis factor antagonists | Q35954490 |
| | Cardiovascular risk in rheumatoid arthritis: comparing TNF-α blockade with nonbiologic DMARDs | Q36361147 |
| | Reduction in the incidence of myocardial infarction in patients with rheumatoid arthritis who respond to anti-tumor necrosis factor alpha therapy: results from the British Society for Rheumatology Biologics Register | Q36732112 |
| | Cardiovascular disease in patients with rheumatoid arthritis: results from the QUEST-RA study | Q36757060 |
| | Systematic review and meta‐analysis: Anti–tumor necrosis factor α therapy and cardiovascular events in rheumatoid arthritis | Q37801353 |
| | Epidemiology of CVD in rheumatic disease, with a focus on RA and SLE. | Q37883018 |
| | Immunosuppressive medications and hospitalization for cardiovascular events in patients with rheumatoid arthritis | Q38465160 |
| | Nationwide prevalence of rheumatoid arthritis and penetration of disease-modifying drugs in Sweden | Q39962493 |
| | The risk of myocardial infarction and pharmacologic and nonpharmacologic myocardial infarction predictors in rheumatoid arthritis: a cohort and nested case-control analysis | Q40053146 |
| | Generalisability of clinical registers used for drug safety and comparative effectiveness research: coverage of the Swedish Biologics Register | Q43796083 |
| | Disease activity as a risk factor for myocardial infarction in rheumatoid arthritis | Q43836845 |
| | Treatment with tumor necrosis factor inhibitors and the risk of acute coronary syndromes in early rheumatoid arthritis | Q44293608 |
| | Cancer risk in patients with rheumatoid arthritis treated with anti-tumor necrosis factor alpha therapies: does the risk change with the time since start of treatment? | Q44536841 |
| | Incidence of rheumatoid arthritis in Sweden: a nationwide population-based assessment of incidence, its determinants, and treatment penetration | Q44545230 |
| | Do cardiovascular risk factors confer the same risk for cardiovascular outcomes in rheumatoid arthritis patients as in non-rheumatoid arthritis patients? | Q45235877 |
| | Rapid increase in myocardial infarction risk following diagnosis of rheumatoid arthritis amongst patients diagnosed between 1995 and 2006. | Q45781042 |
| | Risk of incident cardiovascular events in patients with rheumatoid arthritis: a meta-analysis of observational studies. | Q46003173 |
| | Tumour necrosis factor antagonist use and associated risk reduction of cardiovascular events among patients with rheumatoid arthritis. | Q53725487 |
| | Does rheumatoid arthritis equal diabetes mellitus as an independent risk factor for cardiovascular disease? A prospective study | Q60298067 |
| | High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors | Q77406810 |
| | Antirheumatic drug use and the risk of acute myocardial infarction | Q80016233 |
| | Treatment with tumor necrosis factor blockers is associated with a lower incidence of first cardiovascular events in patients with rheumatoid arthritis | Q81922641 |
| P433 | issue | 3 | |
| P921 | main subject | rheumatoid arthritis | Q187255 |
| | acute coronary syndrome | Q266018 |
| | TNF | Q18032037 |
| P304 | page(s) | R127 | |
| P577 | publication date | 2014-06-18 | |
| P1433 | published in | Arthritis Research and Therapy | Q15757229 |
| P1476 | title | The risk of acute coronary syndrome in rheumatoid arthritis in relation to tumour necrosis factor inhibitors and the risk in the general population: a national cohort study | |
| P478 | volume | 16 | |